As the three-day Labor Day weekend looms on the calendar, here’s a look at where stocks have been and where they’re heading. Read More

The Drug Enforcement Administration just proposed a massive boost in the production of marijuana and psychedelics. Here's why. Read More

IPO activity fell sharply in the second quarter, a sign that investors are growing more cautious and the market bubble is deflating. Read More

What Zoom was worth a year ago during the height of the pandemic bears little relation to what it will be worth a year from now. Read More

Shifting monetary policy is causing worry for investors. Here’s how to profitably leverage the Fed's new course, with downside protection. Read More

Although options have a reputation of being risky, they can be used to reduce the risk of your stock holdings. Read More

The nation’s top federal drug official recently acknowledged that marijuana decriminalization has not corrupted the nation’s youth. Read More

As the global economy enjoys synchronized growth, Europe is jumping to the head of the pack as an investment destination. Read More

This week, we address a reader who asked what it takes to be an analyst. You should always research their credentials. Read More

The Fed’s latest meeting was a plus for stocks, as Fed Chair Powell suggested tapering could begin this year, but with no rate hike. Here's what lays ahead. Read More